Media ReleasesPhylogica

View All Phylogica News


Phylogica, Annual Report for the Year Ended 30 June 2018

Overview of progress in FY18

As a brief recap, major achievements through FY18 included:

1. An investment in our peptide libraries to triple their diversity and therefore richness as a source of drug candidates;

2. Adoption of high throughput screening capability in order to sample the richness of these libraries in identifying our ‘second generation’ of CPPs; and

3. Validation of our CPP platform in vivo (in animals) using our ‘first generation’ of CPPs with the Cre recombinase cargo to demonstrate effective drug delivery into a range of different tissue types.


To view Report please download PDF attached:
Download this document